Learn / BHVN
NYSE: BHVN
Biohaven Ltd. (BHVN) stock, explained like you're 5
Biohaven Ltd. trades on the New York Stock Exchange under the ticker BHVN. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
- Ticker
- BHVN
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 1.8 billion dollars
Is Biohaven Ltd. a small, medium or large cap company?
No. Biohaven Ltd. is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Biohaven Ltd. makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves BHVN stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- BHVN Stock Builds Momentum Ahead Of Multiple H2 2026 Clinical Data Readouts (Stocktwits)
- BHVN News | BIOHAVEN LTD (NYSE:BHVN) (ChartMill)
- BHVN Stock On Track For Best Day In Over 2 Months After SK Biopharmaceuticals Licenses Epilepsy Drug: Retail Now Awaits Obesity Trial Readout (Stocktwits)
- Did Licensing Deal Just Shift Biohaven (BHVN) Investment Narrative? (Simply Wall Street)
- BHVN Stock On Track For Best Day In Over 2 Months After SK Biopharmaceuticals Licenses Epilepsy Drug: Retail Now Awaits Obesity Trial Readout (Yahoo Finance)
Follow BHVN in your daily brief
Each trading day at 5 PM ET we post what happened to Biohaven Ltd. and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow BHVN
Questions about Biohaven Ltd. stock
What does Biohaven Ltd. do?
Biohaven Ltd. trades on the New York Stock Exchange under the ticker BHVN. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.
What is the ticker symbol for Biohaven Ltd.?
Biohaven Ltd. trades under the ticker BHVN on the New York Stock Exchange.
What is Biohaven Ltd.'s market cap?
Biohaven Ltd. is a small cap stock with a market cap of about 1.8 billion dollars.
How does Biohaven Ltd. make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves BHVN stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow BHVN stock every day?
Add BHVN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.